NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung cancer (NSCLC) resections with curative intent, real-world data suggested. The more N1 ...
NEW ORLEANS — January 31, 2026 — Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for ...
Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to ...
Risk Model for Predicting Gaps in Surgical Oncology Care Among Patients With Stage I-III Rectal Cancer From KwaZulu-Natal, South Africa Patients diagnosed with solid-dominant stage I NSCLC between ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Systematic mediastinal lymph node dissection (LND) or sampling is currently recommended for patients with early-stage non–small cell lung cancer. We aimed to investigate whether no mediastinal LND was ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found. A colorized three dimensional micrographic scan of a melanoma cell. Recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results